OmniAb (OABI) Total Liabilities (2021 - 2026)
OmniAb (OABI) reported Total Liabilities of $31.0 million for Q1 2026, down 5.09% year-over-year from $32.7 million in Q1 2025, and down 8.51% quarter-over-quarter from $33.9 million in Q4 2025.
OmniAb (OABI) Total Liabilities (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Total Liabilities data on file, last reported at $31.0 million in Q1 2026.
- Total Liabilities for Q1 2026 came in at $31.0 million, down 5.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $31.0 million (down 5.09% YoY), and the FY2025 annual result was $33.9 million, down 10.68% from the prior year.
- Total Liabilities slipped to $31.0 million in Q1 2026 per OABI's latest filing, from $33.9 million in the prior quarter.
- Over five years, Total Liabilities peaked at $79.8 million in Q4 2022 and troughed at $13.5 million in Q1 2022.
- A 5-year average of $42.9 million and a median of $37.9 million in 2024 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2022 and 2024: Total Liabilities soared 78602.45% in 2022, then sank 40.7% in 2024.
- A 5-year view of Total Liabilities shows it stood at $79.8 million in 2022, then slipped by 24.05% to $60.6 million in 2023, then slumped by 37.43% to $37.9 million in 2024, then slipped by 10.68% to $33.9 million in 2025, then retreated by 8.51% to $31.0 million in 2026.
- Business Quant data shows OABI's Total Liabilities at $31.0 million in Q1 2026, $33.9 million in Q4 2025, and $32.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | 31.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.00 Mn |
| Dec 31, 2025 | 33.89 Mn |
| Sep 30, 2025 | 32.25 Mn |
| Jun 30, 2025 | 33.61 Mn |
| Mar 31, 2025 | 32.67 Mn |
| Dec 31, 2024 | 37.94 Mn |
| Sep 30, 2024 | 39.83 Mn |
| Jun 30, 2024 | 43.08 Mn |
| Mar 31, 2024 | 51.16 Mn |
| Dec 31, 2023 | 60.64 Mn |
| Sep 30, 2023 | 67.16 Mn |
| Jun 30, 2023 | 71.43 Mn |
| Mar 31, 2023 | 72.24 Mn |
| Dec 31, 2022 | 79.84 Mn |
| Sep 30, 2022 | 14.29 Mn |
| Jun 30, 2022 | 15.03 Mn |
| Mar 31, 2022 | 13.51 Mn |
| Dec 31, 2021 | 70.16 Mn |
| Sep 30, 2021 | 8.15 Mn |
| Jun 30, 2021 | 618,386.00 |